BI 1819479: Clinical Trials

1 trial of BI 1819479, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow BI 1819479: new trials by email Literature Review of BI 1819479 trials Research Report on BI 1819479

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
BI 1819479, Placebo matching BI 1819479 - Idiopathic Pulmonary Fibrosis
Phase 2CompletedBoehringer Ingelheim3222024-09-052026-07-27

Conditions studied

Idiopathic Pulmonary Fibrosis (1)

Sponsors

Boehringer Ingelheim (1)

Countries

Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Hungary (1)  ·  Italy (1)

Results publications

PMID 41846682

NIH funding

2023 (1)